StonvexLoading…
StonvexCore line items from OC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.27B | $10.10B | $7.96B | $5.28B |
Operating Income | $120.00M | $360.00M | $585.00M | $912.00M |
Net Income | $-105.00M | $-522.00M | $-224.00M | $270.00M |
EPS (Diluted) | $-1.29 | $-6.22 | $-2.63 | $3.15 |
Total Assets | $13.09B | $12.98B | $13.52B | $14.48B |
Total Liabilities | $9.41B | $9.09B | $9.08B | $9.28B |
Cash & Equivalents | $272.00M | $345.00M | $286.00M | $230.00M |
Free Cash Flow OCF − CapEx | $-387.00M | $962.00M | $629.00M | $-123.00M |
Shares Outstanding | 80.50M | 80.20M | 85.30M | 85.90M |